Literature DB >> 11171631

Ontogenic and longitudinal activity of Na(+)-nucleoside transporters in the human intestine.

L Y Ngo1, S D Patil, J D Unadkat.   

Abstract

The objectives of our study were to identify the types of nucleoside transporters present in the human fetal small intestine and to characterize their developmental activity, longitudinal distribution, and transport kinetics compared with those present in the adult intestine. Nucleoside uptake by intestinal brush-border membrane vesicles was measured by an inhibitor-stop rapid filtration technique. Only the purine-specific (N1; hCNT2) and the pyrimidine-specific (N2; hCNT1) Na(+)-dependent nucleoside transporters were found to be present on the brush-border membranes of the enterocytes along the entire length of the fetal and adult small intestines. The activity of these transporters was higher in the proximal than in the distal small intestine. Both the N1 and N2 transporters found in the fetal intestine shared similar kinetic properties (Michaelis-Menten constant and Na(+)-nucleoside stoichiometry) to those in the adult intestine. During the period of rapid morphogenesis (11-15 wk gestation), no temporal differences were apparent in the activity of the N1 and N2 transporters in the fetal small intestine. These findings have implications for the absorption of drugs from the amniotic fluid by the fetus after maternal drug administration of nucleoside drugs such as the antivirals zidovudine and didanosine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171631     DOI: 10.1152/ajpgi.2001.280.3.G475

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  12 in total

1.  Na+ gradient-dependent transport of hypoxanthine by calf intestinal brush border membrane vesicles.

Authors:  A Theisinger; B Grenacher; E Scharrer
Journal:  J Comp Physiol B       Date:  2003-02-11       Impact factor: 2.200

2.  Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3.

Authors:  Jing Zhang; Tracey Tackaberry; Mabel W L Ritzel; Taylor Raborn; Gerry Barron; Stephen A Baldwin; James D Young; Carol E Cass
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

3.  Molecular determinants of acidic pH-dependent transport of human equilibrative nucleoside transporter 3.

Authors:  Md Fazlur Rahman; Candice Askwith; Rajgopal Govindarajan
Journal:  J Biol Chem       Date:  2017-07-20       Impact factor: 5.157

Review 4.  The concentrative nucleoside transporter family, SLC28.

Authors:  Jennifer H Gray; Ryan P Owen; Kathleen M Giacomini
Journal:  Pflugers Arch       Date:  2003-07-11       Impact factor: 3.657

5.  Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells.

Authors:  Shuy-Vang Toan; Kenneth K W To; George P H Leung; Maria Olivia de Souza; Jeffrey L Ward; Chung-Ming Tse
Journal:  Pflugers Arch       Date:  2003-09-18       Impact factor: 3.657

Review 6.  Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.

Authors:  M Pastor-Anglada; E Errasti-Murugarren; I Aymerich; F J Casado
Journal:  J Physiol Biochem       Date:  2007-03       Impact factor: 4.158

7.  Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes.

Authors:  Rajgopal Govindarajan; Christopher J Endres; Dale Whittington; Edward LeCluyse; Marçal Pastor-Anglada; Chung-Ming Tse; Jashvant D Unadkat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-17       Impact factor: 4.052

8.  Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance.

Authors:  Kristie D Ibarra; Julie K Pfeiffer
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

9.  Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs.

Authors:  Ekaitz Errasti-Murugarren; Marçal Pastor-Anglada; F Javier Casado
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

10.  Adenosine 5'-triphosphate (ATP) supplements are not orally bioavailable: a randomized, placebo-controlled cross-over trial in healthy humans.

Authors:  Ilja Cw Arts; Erik Jcm Coolen; Martijn Jl Bours; Nathalie Huyghebaert; Martien A Cohen Stuart; Aalt Bast; Pieter C Dagnelie
Journal:  J Int Soc Sports Nutr       Date:  2012-04-17       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.